World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
102
Citations
33756
World Ranking
7740
National Ranking
4030

Jeffrey E. Rubnitz publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jeffrey E. Rubnitz sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 416 publications — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jeffrey E. Rubnitz D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jeffrey E. Rubnitz sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 102 D-Index — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jeffrey E. Rubnitz is affiliated with St. Jude Children's Research Hospital in the United States. Their research primarily focuses on the fields of medicine with an emphasis on hematology, molecular biology, public health, oncology, and pediatrics.

The scientist's work encompasses a range of topics related to leukemia, particularly acute myeloid and acute lymphoblastic leukemia, as well as histone deacetylase inhibitors, epigenetics and DNA methylation, protein degradation, cancer genomics, and childhood cancer survivors' quality of life.

Frequent publication venues for Rubnitz include:

  • Blood
  • Blood Advances
  • Leukemia
  • Nature Communications
  • Cancer

Co-authors who have collaborated extensively with Rubnitz include:

  • Raul C. Ribeiro
  • Stanley Pounds
  • Hiroto Inaba
  • Jeffery M. Klco
  • Jatinder K. Lamba

Among the recent papers featuring Rubnitz as an author are:

  • "Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma," 2021, Cancer Discovery
  • "Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology," 2021, Journal of the National Comprehensive Cancer Network
  • "Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study," 2020, The Lancet Oncology
  • "Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease-Directed Therapy," 2021, Blood Cancer Discovery
  • "How I treat pediatric acute myeloid leukemia," 2021, Blood

This publication record demonstrates a focus on leukemia treatment and therapeutic strategies, often addressing pediatric cases and refractory conditions.

Best Publications

  • Treating childhood acute lymphoblastic leukemia without cranial irradiation.

    Ching Hon Pui;Dario Campana;Deqing Pei;W. Paul Bowman

  • Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Charles G. Mullighan;Mihaela Onciu;Frederick G. Behm

  • TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.

    Shurtleff Sa;Buijs A;Behm Fg;Rubnitz Je

  • NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

    Jeffrey E. Rubnitz;Hiroto Inaba;Raul C. Ribeiro;Stanley Pounds

  • A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

    Rob Pieters;Martin Schrappe;Paola De Lorenzo;Ian Hann

  • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Michael L. Hancock;James M. Boyett

  • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

    Elaine Coustan-Smith;Frederick G. Behm;Frederick G. Behm;Joaquin Sanchez;James M. Boyett;James M. Boyett

  • Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial

    Jeffrey E. Rubnitz;Hiroto Inaba;Gary Dahl;Raul C. Ribeiro

  • Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

    Kirk R. Schultz;D. Jeanette Pullen;Harland N. Sather;Jonathan J. Shuster

  • Improved outcome for children with acute lymphoblastic leukemia: Results of Total Therapy Study XIIIB at St Jude Children's Research Hospital

    Ching Hon Pui;John T. Sandlund;Deqing Pei;Dario Campana

  • High incidence of secondary brain tumours after radiotherapy and antimetabolites

    Mary V. Relling;Mary V. Relling;Jeffrey E. Rubnitz;Jeffrey E. Rubnitz;Gaston K. Rivera;Gaston K. Rivera;James M. Boyett;James M. Boyett

  • Gene expression profiling of pediatric acute myelogenous leukemia.

    Mary E. Ross;Rami Mahfouz;Mihaela Onciu;Hsi Che Liu

  • Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study.

    Brian V. Balgobind;Susana C. Raimondi;Susana C. Raimondi;Jochen Harbott;Martin Zimmermann

  • Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia

    Deepa Bhojwani;Noah D. Sabin;Deqing Pei;Jun J. Yang

  • Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia.

    Elaine Coustan-Smith;Jose Sancho;Frederick G. Behm;Michael L. Hancock

  • Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia

    Nobuko Hijiya;Melissa M. Hudson;Shelly Lensing;Margie Zacher

  • Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia

    C.-H. Pui;C.-H. Pui;D. Pei;Jt T. Sandlund;Jt T. Sandlund;Rc C. Ribeiro;Rc C. Ribeiro

  • The minimum amount of homology required for homologous recombination in mammalian cells.

    J Rubnitz;S Subramani

  • Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia

    C. Michel Zwaan;Edward A. Kolb;Dirk Reinhardt;Jonas Abrahamsson

  • The genetic basis and cell of origin of mixed phenotype acute leukaemia

    Thomas B. Alexander;Thomas B. Alexander;Zhaohui Gu;Ilaria Iacobucci;Kirsten Dickerson

Frequent Co-Authors

Raul C. Ribeiro
Raul C. Ribeiro St. Jude Children's Research Hospital
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Stanley Pounds
Stanley Pounds St. Jude Children's Research Hospital
John T. Sandlund
John T. Sandlund National Institutes of Health
Susana C. Raimondi
Susana C. Raimondi St. Jude Children's Research Hospital
James R. Downing
James R. Downing St. Jude Children's Research Hospital
Mary V. Relling
Mary V. Relling St. Jude Children's Research Hospital
Dario Campana
Dario Campana National University of Singapore
William E. Evans
William E. Evans St. Jude Children's Research Hospital
Scott C. Howard
Scott C. Howard University of Tennessee Health Science Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and complementary career pathways in healthcare can open up many opportunities alongside, or outside of, a traditional medical degree. For those interested in the administrative side, earning a degree in healthcare administration can lead to leadership positions in hospitals and clinics, handling vital decisions that impact patient care and overall efficiency.

Nursing professionals looking to advance can enroll in rn to np bridge programs, which allow registered nurses to become nurse practitioners—offering greater autonomy and responsibility in patient care. Meanwhile, those passionate about diet and health can pursue an online dietitian degree and build careers helping individuals manage wellbeing through nutrition.

For aspiring healthcare managers, enrolling in top cahme accredited mha programs is an excellent way to gain the advanced business skills needed for success in healthcare organizations. Many of these pathways are available fully online, offering flexibility for busy students or working professionals.

Best Scientists Citing Jeffrey E. Rubnitz

Trending Scientists

Recently Published Articles